Application

S

Strateos, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90623925
Filing Date: 04/05/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90623925
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT S
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a stylized letter "S" made up of curved lines and circles.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 400 x 331
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Strateos, Inc.
*MAILING ADDRESS 3565 Haven Avenue, Suite 3
*CITY Menlo Park
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94025
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic biology, agscience and medical device industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, and pharmacovigilance; software as a service ("SAAS") enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage their scientific data. software as a service ("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service ("SAAS") featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service ("SAAS") for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services for pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 09/23/2019
       FIRST USE IN COMMERCE DATE At least as early as 09/23/2019
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-2600170064ce119084be c3d2f9c34c7a-202104021129 41585858_._Strateos_Logo- Specimen_of_Use_1.pdf
       CONVERTED PDF FILE(S)
       (8 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0006.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0007.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0008.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0009.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0010.JPG
       ORIGINAL PDF FILE SPE0-2600170064ce119084be c3d2f9c34c7a-202104021129 41585858_._Strateos_Logo- Specimen_of_Use_2.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0011.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0012.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0013.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0014.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0015.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\906\239\90623925\xml1\ APP0016.JPG
       SPECIMEN DESCRIPTION screenshots from website
        WEBPAGE URL http://www.strateos.com/robotic-cloud-lab/
        WEBPAGE DATE OF ACCESS 04/02/2021
        WEBPAGE URL http://www.strateos.com/strateos-console/
        WEBPAGE DATE OF ACCESS 04/02/2021
ATTORNEY INFORMATION
NAME Stacey J. Watson, Esq.
ATTORNEY DOCKET NUMBER US-STR-002A
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Markery Law LLC
STREET P.O. Box 84150
CITY Gaithersburg
STATE Maryland
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20883-4150
PHONE 202-888-7786
FAX (202) 803-7953
EMAIL ADDRESS docket@markerylaw.com
OTHER APPOINTED ATTORNEY Katrina G. Hull, Jacqueline L. Patt
CORRESPONDENCE INFORMATION
NAME Stacey J. Watson, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docket@markerylaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) staceywatson@markerylaw.com; taratoth@markerylaw.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE //Marc Siladi//
SIGNATORY'S NAME Marc Siladi
SIGNATORY'S POSITION Senior Director of Marketing
DATE SIGNED 04/02/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90623925
Filing Date: 04/05/2021

To the Commissioner for Trademarks:

MARK: S (stylized and/or with design, see mark)
The literal element of the mark consists of S. The mark consists of a stylized letter "S" made up of curved lines and circles.
The applicant, Strateos, Inc., a corporation of Delaware, having an address of
      3565 Haven Avenue, Suite 3
      Menlo Park, California 94025
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic biology, agscience and medical device industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, and pharmacovigilance; software as a service ("SAAS") enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage their scientific data. software as a service ("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service ("SAAS") featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service ("SAAS") for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services for pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/23/2019, and first used in commerce at least as early as 09/23/2019, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) screenshots from website.

Original PDF file:
SPE0-2600170064ce119084be c3d2f9c34c7a-202104021129 41585858_._Strateos_Logo- Specimen_of_Use_1.pdf
Converted PDF file(s) (8 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Original PDF file:
SPE0-2600170064ce119084be c3d2f9c34c7a-202104021129 41585858_._Strateos_Logo- Specimen_of_Use_2.pdf
Converted PDF file(s) (6 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Webpage URL: http://www.strateos.com/robotic-cloud-lab/
Webpage Date of Access: 04/02/2021
Webpage URL: http://www.strateos.com/strateos-console/
Webpage Date of Access: 04/02/2021




The owner's/holder's proposed attorney information: Stacey J. Watson, Esq.. Other appointed attorneys are Katrina G. Hull, Jacqueline L. Patt. Stacey J. Watson, Esq. of Markery Law LLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      P.O. Box 84150
      Gaithersburg, Maryland 20883-4150
      United States
      202-888-7786(phone)
      (202) 803-7953(fax)
      docket@markerylaw.com
The docket/reference number is US-STR-002A.
Stacey J. Watson, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Stacey J. Watson, Esq.
       PRIMARY EMAIL FOR CORRESPONDENCE: docket@markerylaw.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): staceywatson@markerylaw.com; taratoth@markerylaw.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: //Marc Siladi//   Date: 04/02/2021
Signatory's Name: Marc Siladi
Signatory's Position: Senior Director of Marketing
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90623925
Payment Accounting Date: 04/05/2021

Serial Number: 90623925
Internet Transmission Date: Mon Apr 05 14:33:34 ET 2021
TEAS Stamp: USPTO/BAS-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210405143334487048-90623925-
770f250bfb326adaca8fe4b381816542efca96d9
3b4981cca48b5d9fc8aeec8c-CC-33334650-202
10402112941585858

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed